Literature DB >> 36254386

Correlation between serum cystatin C level and renal microvascular perfusion assessed by contrast-enhanced ultrasound in patients with diabetic kidney disease.

Ping Zhao1,2, Nan Li2, Lin Lin2, Qiuyang Li2, Yiru Wang2, Yukun Luo1,2,3.   

Abstract

OBJECTIVES: To investigate the relationship between serum cystatin C (CysC) levels and renal microvascular perfusion in patients with diabetic kidney disease (DKD).
METHODS: A total of 57 patients with high CysC levels and 45 patients with normal CysC levels were enrolled. Data on clinical characteristics and laboratory examination results were also collected. Contrast-enhanced ultrasound (CEUS) of the kidneys was successively performed. The time-intensity curve (TIC) and related quantitative parameters of the kidneys were obtained by CEUS and the correlations between CysC and CEUS parameters were analyzed.
RESULTS: Compared to the normal CysC group, the high CysC group had significantly lower wash-in area under the curve (WiAUC), wash-out area under the curve (WoAUC), and wash-in and wash-out area under the curve (WiWoAUC). In the normal CysC group, patients with Stage III chronic kidney disease (CKD) had higher AUCs than those with Stage I-II CKD (p < 0.05). In the high CysC group, patients with Stage IV-V CKD had lower wash-in AUC compared to patients with Stage I-II CKD (p = 0.023). The renal cortex microvascular perfusion parameters AUCs were positively correlated with the estimated glomerular filtration rate (GFR) (r = 0.280, 0.222, and 0.243), and CysC was inversely correlated with AUCs (r= -0.299, -0.251, and -0.273).
CONCLUSIONS: CEUS parameters reflected changes in renal microvascular perfusion in patients with DKD, while AUCs might be useful indicators of declining GFR in DKD patients with increased CysC.

Entities:  

Keywords:  Ultrasound; contrast-enhanced ultrasound; cystatin C; diabetic kidney disease

Mesh:

Substances:

Year:  2022        PMID: 36254386      PMCID: PMC9586683          DOI: 10.1080/0886022X.2022.2134026

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   3.222


  29 in total

1.  Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C.

Authors:  Hans Pottel; Pierre Delanaye; Elke Schaeffner; Laurence Dubourg; Bjørn Odvar Eriksen; Toralf Melsom; Edmund J Lamb; Andrew D Rule; Stephen T Turner; Richard J Glassock; Vandréa De Souza; Luciano Selistre; Karolien Goffin; Steven Pauwels; Christophe Mariat; Martin Flamant; Natalie Ebert
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

Review 2.  Contrast-enhanced ultrasound: A promising method for renal microvascular perfusion evaluation.

Authors:  Ling Wang; Chandra Mohan
Journal:  J Transl Int Med       Date:  2016-09-23

Review 3.  Cystatin C: an emerging biomarker in cardiovascular disease.

Authors:  Christos Angelidis; Spyridon Deftereos; Georgios Giannopoulos; Nikolaos Anatoliotakis; Georgios Bouras; Georgios Hatzis; Vasiliki Panagopoulou; Vlasios Pyrgakis; Michael W Cleman
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 4.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

5.  Serum cystatin C as an indicator for early detection of diabetic nephropathy in type 2 diabetes mellitus.

Authors:  Mohamed Shawky Elsayed; Ayman El Badawy; Abdelmon'em Ahmed; Rasha Omar; Amr Mohamed
Journal:  Diabetes Metab Syndr       Date:  2018-08-28

6.  Cystatin C and Neutrophil Gelatinase-Associated Lipocalin as Early Biomarkers for Chronic Kidney Disease in Dogs.

Authors:  Hui-Yeon Ko; Joonyoung Kim; Migyeong Geum; Ha-Jung Kim
Journal:  Top Companion Anim Med       Date:  2021-08-21

7.  Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.

Authors:  Ian H de Boer
Journal:  Diabetes Care       Date:  2014       Impact factor: 19.112

8.  Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials.

Authors:  Christian Mende; Arie Katz
Journal:  Diabetes Ther       Date:  2016-02-22       Impact factor: 2.945

9.  Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2017-09-16       Impact factor: 79.321

10.  Estimation of kidney function in patients with primary neuromuscular diseases: is serum cystatin C a better marker of kidney function than creatinine?

Authors:  Annika Aldenbratt; Christopher Lindberg; Elias Johannesson; Ola Hammarsten; Maria K Svensson
Journal:  J Nephrol       Date:  2021-08-05       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.